Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.77 USD | +5.90% | +13.55% | -11.71% |
05-31 | Prelude Therapeutics Files for $400 Million Mixed Shelf | MT |
05-07 | Prelude Therapeutics Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.71% | 196M | |
+55.70% | 55.7B | |
+41.08% | 39.91B | |
-5.39% | 39.57B | |
-5.56% | 28.16B | |
+16.46% | 26.3B | |
-20.56% | 18.94B | |
+33.03% | 12.17B | |
+25.85% | 12.12B | |
+2.72% | 12.12B |
- Stock Market
- Equities
- PRLD Stock
- News Prelude Therapeutics Incorporated
- Prelude Therapeutics Incorporated Announces Resignation of Christopher Pierce as Executive Vice President and Chief of Business Operations, Effective on September 30, 2021